Nanaki, S.;                     Barmpalexis, P.;                     Iatrou, A.;                     Christodoulou, E.;                     Kostoglou, M.;                     Bikiaris, D.N.    
        Risperidone Controlled Release Microspheres Based on Poly(Lactic Acid)-Poly(Propylene Adipate) Novel Polymer Blends Appropriate for Long Acting Injectable Formulations. Pharmaceutics 2018, 10, 130.
    https://doi.org/10.3390/pharmaceutics10030130
    AMA Style
    
                                Nanaki S,                                 Barmpalexis P,                                 Iatrou A,                                 Christodoulou E,                                 Kostoglou M,                                 Bikiaris DN.        
                Risperidone Controlled Release Microspheres Based on Poly(Lactic Acid)-Poly(Propylene Adipate) Novel Polymer Blends Appropriate for Long Acting Injectable Formulations. Pharmaceutics. 2018; 10(3):130.
        https://doi.org/10.3390/pharmaceutics10030130
    
    Chicago/Turabian Style
    
                                Nanaki, Stavroula,                                 Panagiotis Barmpalexis,                                 Alexandros Iatrou,                                 Evi Christodoulou,                                 Margaritis Kostoglou,                                 and Dimitrios N. Bikiaris.        
                2018. "Risperidone Controlled Release Microspheres Based on Poly(Lactic Acid)-Poly(Propylene Adipate) Novel Polymer Blends Appropriate for Long Acting Injectable Formulations" Pharmaceutics 10, no. 3: 130.
        https://doi.org/10.3390/pharmaceutics10030130
    
    APA Style
    
                                Nanaki, S.,                                 Barmpalexis, P.,                                 Iatrou, A.,                                 Christodoulou, E.,                                 Kostoglou, M.,                                 & Bikiaris, D. N.        
        
        (2018). Risperidone Controlled Release Microspheres Based on Poly(Lactic Acid)-Poly(Propylene Adipate) Novel Polymer Blends Appropriate for Long Acting Injectable Formulations. Pharmaceutics, 10(3), 130.
        https://doi.org/10.3390/pharmaceutics10030130